NCT02691117|TerminatedPhase 3
Study Stopped
Lack of efficacy of the study medication
Loading search results
Sponsor study identifier
interventional
8
1 country
1
Study Start
January 10, 2016
Actual (reported)Primary Completion
August 15, 2017
Actual (reported)Study Completion
December 1, 2017
Actual (reported)Management of pediatric alopecia is particularly challenging given the chronicity of the condition, limited therapeutic response and devastating psychological effects. There is a paucity of safe and effective therapies in this population. The investigators propose to conduct and open label, prospective cohort pilot study using topical garlic concentrate ( GarlicRich) for treatment of children with alopecia areata. Study medication will be applied topically on affected area of the skin daily for 6 months. Follow up visits will occur monthly to access the efficacy and safety of the proposed treatment .
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 15, 2015
Actual (reported)January 10, 2016
Actual (reported)February 25, 2016
Actual (reported)August 15, 2017
Actual (reported)December 1, 2017
Actual (reported)Percentage change of SALT scores at 6 months compared to baseline.
Percentage change of SALT scores at 6 months compared to baseline
6 months
Categorical percent hair regrowth
6 months
Proportion of subjects with at least 70% hair regrowth using the percent scalp hair regrowth based on SALT score.
6 months
Density of hair regrowth at 6 months
6 months
Type of hair regrowth at 6 months
6 months
Parental/patient assessment of hair regrowth using a 100 mm visual analog scale with 3 anchors (total loss, no change, full regrowth) where 5 mm corresponds to 10% change
6 months
Garlic gel concentrate- once a day topical application
Topical application of GarlicRich gel on the scalp areas affected with alopecia areata once a day for 6 months
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Th Hospital for Sick Children
Toronto, Ontario, M5G1X8, Canada
Elena Pope, MD, MSc
The Hospital for Sick Children
8 participants (actual enrollment reported by the registry).
First Submitted
December 15, 2015
First Posted
February 25, 2016
Study Start
January 10, 2016
Actual (reported)A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Contact the study team to confirm eligibility.
Primary Completion
August 15, 2017
Actual (reported)Study Completion
December 1, 2017
Actual (reported)Last Updated
April 19, 2018
Record last verified: 2018-04
only aggregated data will be available to participants
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: